WEON 2024 > Programme > Parallel Sessions

Parallel Sessions

Parallel Session 1
May 29 - 14:00 - 15:15
Hendrik Marsman - Sustainability
14:00OP.1.01Tipping the balance of protein transition: An agent-based model of cross-contextual spillover effects of interventions at the workplace on types of protein consumption at home settingsYinjie Zhu
14:15OP.1.02Greenspace, air pollution, and mortalityIna Rissanen
14:30OP.1.0330km/h speed limits for better public health: Meta-narrative evidence synthesis of the evidenceCarel-Peter van Erpecum *
14:45OP.1.04Reporting of sustainability outcomes and design considerations in clinical trials: an explorative systematic reviewFlorien van Royen
15:00OP.1.05Towards sustainable use of devices in healthcareMarjan Alssema
Springer - Methodology I
14:00OP.2.01Development and internal validation of mammography feature-based prognostic models for distant recurrence-free survival of invasive breast cancer in a screening cohortJim Peters
14:15OP.2.02Does conducting clinical trials at home improve participant representativeness?Amos de Jong
14:30OP.2.03Evaluation of semi-automated screening tool performance in title-abstract screening for systematic reviews of intervention and prognosisIsa Spiero
14:45OP.2.04Surveillance of antibiotic use in Dutch long term care facilities: prescriptions versus dispensesMirthe Biesheuvel
15:00OP.2.05Illustrating the consequences of plug-and-play use of tree-based models for clinical prediction modelingLotta Meijerink
Copijn - Oncology I
14:00OP.3.01Early life adiposity and adult breast cancer risk: dose-response meta-analyses of prospective studies within the Global Cancer Update Programme (CUP Global)Moniek van Zutphen *
14:15OP.3.02Socioeconomic inequalities in cancer incidence and stage at diagnosis in the Netherlands: a nationwide population-based studyMeggie Drissen
14:30OP.3.03An optimal 25-hydroxyvitamin D status is potentially inversely associated with the development of colorectal neoplasms in individuals with Lynch syndromeMarjolein Bulbaai
14:45OP.3.04Feasibility and diagnostic value of menstrual cycle timing for breast MRI screening: Practical challenges and impact on diagnostic accuracy observed in the DENSE TrialSophie van Grinsven
15:00OP.3.05Fluid intake and risk of recurrence and progression in patients with non-muscle invasive bladder cancerIvy Beeren
Zocher - Diabetes
14:00OP.4.01Physical examination in phase 3 and 4 drug interventional type 2 diabetes mellitus clinical trial protocols – what is to be done and why?Julia Kopanz
14:15OP.4.02Associations between chronotype waist circumference, visceral fat, liver fat, and incidence of type 2 diabetesJeroen van der Velde
14:30OP.4.03Sex hormone-binding globulin may explain sex differences for glucose homeostasis and incidence of type 2 diabetes: The KORA studyHamidreza Raeisi-Dehkordi #
14:45OP.4.04What drives the decision to participate in a clinical trial from home? – a focus group study in persons living with type 2 diabetes mellitusJulia Kopanz
15:00OP.4.05Towards personalised medicine: the potential of intensive longitudinal data to assess the interplay of chronic diseasesSanne van Dijk *
Parallel Session 2
May 29 - 15:45 - 17:00
Hendrik Marsman - Global Health
15:45OP.1.06Multidimensional energy poverty and acute respiratory infection in children under five years of age: evidence from 22 low- and middle-income countriesMerel Stevens
16:00OP.1.07Association between prenatal multiple micronutrient supplements and pregnancy outcomes; A prospective longitudinal study in Parepare, IndonesiaSabaria Manti Battung
16:15OP.1.08Timing of selection of medicines for diabetes, hepatitis C, HIV, oncology and tuberculosis on National Essential Medicines Lists compared to the WHO Model ListMoska Hellamand
16:30OP.1.09The impact of a novel drug regimen in accelerating lymphatic filariasis elimination in Africa: a mathematical modelling studyAnanthu James
16:45OP.1.10Pathways of Improved Nutritional Status of Under-five Children in Bangladesh Through Women's Empowerment, Food intake and Health Seeking BehaviourSaira Parveen Jolly #
Springer - Oncology II
15:45OP.2.06Hormonal contraceptive use around menopause and its association with breast densitySophie van Grinsven
16:00OP.2.07Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel diseaseSjoerd Elias
16:15OP.2.08The role of cardiometabolic disease in the association of coffee consumption with all-cause mortality in colorectal cancer patientsAbisola Oyelere
16:30OP.2.09Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality: a longitudinal analysisVera Wesselink
16:45OP.2.10BRCA1/2 tumour testing in epithelial ovarian cancer: adherence to guidelines in a real-world setting in the Northern NetherlandsLieke Lanjouw
Copijn - Lifestyle and Nutrition
15:45OP.3.06Integration of Well-being into Health Impact AssessmentXuan Chen
16:00OP.3.07Exercise effect on depression in patients with cancer varies by patient characteristics: An Individual Participant Data Meta-analysis of 26 randomized controlled trialsMarlou-Floor Kenkhuis
16:15OP.3.08Heritability of Stress Exposures: Insights from the Lifelines CohortFelix Reichelt #
16:30OP.3.09Association between metabolomics-based biomarker scores and 10-year cognitive decline in men and women. The Doetinchem Cohort StudyAnnelot Smit
16:45OP.3.10Dietary patterns derived using reduced rank regression in postmenopausal women and risk of mortality: a population-based studyMojgan Amiri
Zocher - Perinatal and Pediatric Epidemiology
15:45OP.4.06Trends in total and live birth prevalence of orofacial clefts and the effect of prenatal detection on pregnancy outcome in the northern NetherlandsSofia Anania #
16:00OP.4.07The interplay between psychological wellbeing, stress, loneliness, and suicidal ideation among Dutch youth: a multi-wave cross-lagged studyStella Brugman
16:15OP.4.08Influence of fine particular matter and environmental green spaces on the infant’s neurodevelopmentJackline Vicent Mbishi
16:30OP.4.09The impact of a changing environment on child health: opportunities in a large dynamic cohort studyMaartje Basten
16:45OP.4.10The survival disparity between children and adolescents and young adults (AYAs) with Ewing sarcoma in the Netherlands did not change since the 1990s despite improved survival: a population-based studyMaya Schulpen
Parallel Session 3
May 30 - 11:00 - 12:30
Hendrik Marsman - Infectious Diseases
11:00OP.1.11Use of passive samplers as wastewater monitoring tool during a mumps outbreak: a proof-of-concept studyAart Dijkstra
11:15OP.1.12Assessment of SNP distance cut-offs for Mycobacterium tuberculosis transmission without contact dataBastiaan van der Roest
11:30OP.1.13Quality of and methodological heterogeneity in COVID-19 Vaccine safety studies – Case study of the myocarditis safety signalTu Pham Hien Trang
11:45OP.1.14Effectiveness of Omicron XBB.1.5 vaccine against SARS-CoV-2 Omicron XBB and JN.1 infection in a prospective cohort study in the Netherlands, October 2023 to March 2024Anne Huiberts *
12:00OP.1.15Impact of adherence and stringency on the effectiveness of lockdown measures: a modelling studyJoren Brunekreef
12:15OP.1.16Federated learning as a smart tool for data analysis in infectious disease research: a scoping reviewLaura Zwiers
Springer - Methodology II
11:00OP.2.11Clinical utilization of prediction models without sufficient validation or impact assessment: a prospective cohort studyBanafsheh Arshi
11:15OP.2.12Data-driven causal discovery for agnostic analyses: current state and implications for exposome studiesSalome Kakhaia
11:30OP.2.13How tailored recruitment activities contribute to the inclusion of a diverse study population for a unique dynamic youth cohort studyMarileen Wiegersma
11:45OP.2.14Comparison of air pollution mortality effect estimates using different long-term exposure assessment methodsFemke Bouma
12:00OP.2.15Validation of the incidence of reported periprosthetic joint infections in total hip and knee prostheses in the Dutch Arthroplasty RegisterMirthe van Veghel
12:15OP.2.16Measurement error in healthcare records and pooled cohort dataValentijn de Jong
Copijn - Cardiovascular Disease
11:00OP.3.11Differential effects of air pollution on incident ischemic heart disease and stroke by ethnicity: a nationwide follow-up analysis in the NetherlandsLieke van den Brekel
11:15OP.3.12Changes in neighbourhood walkability and incident CVD: a population-based cohort study of three million adults covering 24 yearsPaul Meijer *
11:30OP.3.13Early identification of the association between rofecoxib and cardiovascular adverse events using real-world data from the UK: A case-control and case-crossover designDonya Moslemzadeh #
11:45OP.3.14Interaction between lifestyle and polygenic risk in hypertension: insights from the Lifelines Cohort StudyAnna Argoty Pantoja
12:00OP.3.15Associations of dietary fatty acids with the incidence of carotid atherosclerotic plaque components: a prospective studyLuoshiyuan Zuo
12:15OP.3.16Identifying and profiling patients with heart failure in a population-based cohort through linkage of primary and secondary care dataEleonora Iob
Zocher - COREON
11:00COREONAnonymity after anonymising dataBart Torensma & Daniël Groos
* Nominated for Oral Presentation Award
# Nominated for Student Award